1. U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing CrossContamination, 2013. https://www.fda.gov/files/drugs/published/Non-Penicillin-Beta-Lactam-Drugs--A-CGMP-Framework-for-Preventing-Cross-Contamination.pdf (accessed 20/3/2022).
2. Guide to Inspections of Validation of Cleaning Processes;Food and Drug Administration,1993
3. R.S. Hikkaduwa Koralege, E.R.E. Mojica, B.S. Murdianti, P.J. Pham, Penicillins;Dumancas,2014
4. EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities, EMA/CHMP/CVMP/SWP/169430/2012.
5. Determination of Beta-Lactam residues in milk by high performance liquid chromatography;Brito;Braz. Arch. Biol. Technol.,2006